Integrum (publ) announced that the company's OPRA Implant system is approved by FDA to be used in a clinical study on below-knee amputations in the US. The clinical study will be important for the future approval of the OPRA?? Implant System on the below-knee amputations level, which is the most frequent amputation level.

The study will be performed by the Walter Reed National Military Medical Center.